Article
Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jul 2012
Heemann Christina, Kreuz Markus, Stoller Irene, Schoof Nils, von Bonin Frederike, Ziepert Marita, Löffler Markus, Jung Wolfram, Pfreundschuh Michael, Trümper Lorenz, Kube Dieter
Abstract excerpt
PURPOSE: Peripheral T-cell non-Hodgkin lymphomas (T-NHL) represent a small but heterogeneous and clinically aggressive subset of NHLs with a poor outcome. Cytokines or their receptors might be associated with the clinical outcome of these lymphomas. Therefore, we tested whether gene variations and serum levels of soluble TNF receptor (TNFR)I (sTNFRI), sTNFRII, interleukin (IL)-10, or sIL-4R are predictive for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
